Disseminated Fusarium oxysporum infection in hemophagocytic lymphohistiocytosis

Infection

Volumn 32, Issue 6, 2004, Pages 364-366

  Albisetti, M ^a   Lauener, R P ^a   Gungor T ^a   Schar G ^b   Niggli, F K ^a   Nadal, D ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CYCLOSPORIN A; DEXAMETHASONE; ETOPOSIDE; ITRACONAZOLE; MEROPENEM; METHOTREXATE; PREDNISONE; TEICOPLANIN; THYMOCYTE ANTIBODY;

ARTICLE; CASE REPORT; DEVICE INFECTION; FUSARIUM OXYSPORUM; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; NASOGASTRIC TUBE; NEUTROPENIA; PRESCHOOL CHILD;

FUSARIUM; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; INFANT; INTUBATION, GASTROINTESTINAL; MALE; MYCOSES; NEUTROPENIA;

EID: 12144255783     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-004-3135-8     Document Type: Article

References (15)

1. Nelson PE, Dignani MC, Anaissie EJ: Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev 1994; 7: 479-504.
2. Guarro J, Gené J: Opportunistic fusarial infections in humans. Eur J Clin Microbiol Infect Dis 1995; 14: 741-754.
3. Martino P, Gastaldi R, Raccah R, Girmenia C: Clinical pattern of Fusarium infections in immunocompromised patients. J Infect 1994; 28: 7-15.
4. Prinz C, Chavaz P, Tamm K, Hauser C: Ecthyma gangrenosum-like lesions: a sign of disseminated Fusarium infections in the neutropenic patient. Clin Exp Dermatol 1995; 20: 428-430.
5. Boutati El, Anaissie EJ: Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood 1997; 90: 999-1008.
6. Caux F, Aractingi S, Baurmann H, Reygagne P, Dombret H, Romand S, Dubertret L: Fusarium solani cutaneous infection in a neutropenic patient. Dermatology 1993; 186: 232-235.
7. Bushelman SJ, Callen JP, Roth DN, Cohen LM: Disseminated Fusarium solani infection. J Am Acad Dermatol 1995; 32: 346-351.
8. Henter J, Arico M, Egeler M, Elinder G, Favara BE, Filipovich AH, Gadner H, Imashuku S, Janka-Schaub G, Komp D, Ladisch S, Webb D: HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 1997; 28: 342-347.
9. Manual of clinical microbiology (7th edn). Murray PR, Baron, EJ, Pfaller MA, Tenover FC, Yolken RH (eds). ASM Press, Washington, DC 1999.
10. Anaissie E, Nelson P, Beremand M, Kontoyiannis D, Rinaldi M: Fusarium - caused hyalohyphomycosis - an overview. In: Borgers M, Hay R, Rinaldi MG (eds): Current topics in medical mycology. Springer-Verlag, New York 1992, pp 231-249.
11. Ammari LK, Puck JM, McGowan KL: Catheter-related Fusarium solani fungemia and pulmonary infection in a patient with leukemia in remission. Clin Infect Dis 1993; 16: 148-150.
12. Velasco E, Martins CA, Nucci M: Successful treatment of catheter-related fusarial infection in immunocompromised children. Eur J Clin Microbiol Infect Dis 1995; 14: 697-699.
13. Repiso T, García-Patos V, Martin N, Creus M, Bastida P, Castells A: Disseminated fusariosis. Pediatr Dermatol 1996; 13: 118-121.
14. Kerr CM, Perfect JR, Craven PC, Jorgensen JH, Drutz DJ, Shelburne JD, Gallis HA, Gutman RA: Fungal peritonitis in patients in continuous ambulatory peritoneal dialysis. Ann Intern Med 1983; 99: 334-336.
15. Mangini C, de Camargo B: Fungal infection due to Fusarium (spp) in children with refractory hematologic malignancies. Med Pediatr Oncol 1999; 32: 149-150.